Introducing New Pharma Products Into Emerging BRIC Markets
16th April 2012 — 18th April 2012

Capitalise on the Successful Emerging Market Stories to Plan Your Next Venture

Conference focus:

With product pipelines for blockbuster drugs drying up, companies are looking for new channels to secure and maximise revenue. Not only are they now looking at opportunities of new promising drugs, but also the potential of emerging markets to maximise revenue. This is aligned with the exponential growth seen in many emerging markets – especially the BRIC. However, gaining access to new markets, from a regulatory standpoint, understanding local culture and demographics is not easy – even if you are introducing an established product. This marcus evans conference will provide pharma with a comprehensive outlook on how to forecast performance, remove barriers for entry and innovation, overcome regulatory hurdles and establish brand across various emerging markets to guarantee handsome returns. It’s time to open up the untapped potential!

Conference speakers:

Premnath Shenoy
Regulatory Affairs Director
Astrazeneca

Alex White
Vice President & Head Immunology& Hepatitis Centre of Excellence
GSK

Olga Bogdanovich
Sales and Operations Analytics Manager
Johnson & Johnson

Pierre A Morgon
Vice President, Franchise & Global Marketing Strategy
Sanofi Pasteur

Harald Nusser
Vice President, Portfolio Management
Bayer Healthcare

Alex Kudrin
Medical Director, Gastroenterologyand Immunology/Inflammation Clinical Science
Takeda Global Research & Development Centre (Europe)

Prisha Patel
Portfolio Manager
Centre for Innovation in Regulatory Science

Sylvie Duclaux
Senior Director, Head of transverse projects and support
Sanofi Aventis

Fabiana D’Aniello
Head of Drug Development
Ferrer Group

Uwe Gudat
Medical Director
Merck Serono

Satya Mahesh
Senior Manager, Systems & Projects
Sanofi

Paul Royall
Lecturer in Pharmaceutics, Programme Director
Kings College London

Gabriel Kleiman
Assistant General Counsel
Pfizer

Gerard Soula
President & Chief Executive Officer
Adocia

Kulwant Pawar
Professor of Operations Management
Nottingham Business School

Suggested Attendees

Directors, Heads and managers of emerging markets, business development and market access

Expected Number of Attendees

100-200

View Conference Website: Introducing New Pharma Products Into Emerging BRIC Markets

Price of Attendance

n/a

Brochure

View Event Brochure

Location

London
London
London
United Kingdom
London